Report #2862393

Received Sep 30, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 66 yrs
State: PA
Recovered: Recovered
Vaccinated: Sep 24, 2025
Onset: Sep 25, 2025
Days to onset: 1
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
COVID19	COVID19 (COVID19 (MODERNA MNEXSPIKE))	MODERNA	UNK	3052586	IM

Symptoms (5)

AstheniaDiarrhoeaHeadacheHyperhidrosisNausea

Symptom narrative

weakness; sweating; diarrhea; headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weakness), HYPERHIDROSIS (sweating), DIARRHOEA (diarrhea), HEADACHE (headache) and NAUSEA (nausea) in a 66-year-old male patient who received mRNA-1273.251 (Spikevax LP.8.1 PFS) (batch no. 3052586) for COVID-19 prophylaxis. No Medical History information was reported. On 24-Sep-2025, the patient received dose of mRNA-1273.251 (Spikevax LP.8.1 PFS) (Intramuscular use) .5 milliliter. On 25-Sep-2025, the patient experienced ASTHENIA (weakness), HYPERHIDROSIS (sweating), DIARRHOEA (diarrhea), HEADACHE (headache) and NAUSEA (nausea). At the time of the report, ASTHENIA (weakness), HYPERHIDROSIS (sweating), DIARRHOEA (diarrhea), HEADACHE (headache) and NAUSEA (nausea) had resolved. The concomitant medication was not reported by the reporter. On the evening of 25-Sep-2025, the patient experienced severe weakness, headache, diarrhea, sweating and severe nausea that lasted for 6 hours. It was unknown if the patient experienced any additional symptoms or events. The treatment medication was not reported by the reporter.